[go: up one dir, main page]

ATE205072T1 - Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung - Google Patents

Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung

Info

Publication number
ATE205072T1
ATE205072T1 AT98954562T AT98954562T ATE205072T1 AT E205072 T1 ATE205072 T1 AT E205072T1 AT 98954562 T AT98954562 T AT 98954562T AT 98954562 T AT98954562 T AT 98954562T AT E205072 T1 ATE205072 T1 AT E205072T1
Authority
AT
Austria
Prior art keywords
cosmetic composition
compound
indigotype
composition containing
radical
Prior art date
Application number
AT98954562T
Other languages
English (en)
Inventor
Michel Philippe
Jean-Christophe Henrion
Nathalie Guillier-Berteuil
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE205072T1 publication Critical patent/ATE205072T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42—Colour properties
    • A61K2800/43—Pigments; Dyes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Pigments, Carbon Blacks, Or Wood Stains (AREA)
AT98954562T 1997-11-21 1998-11-12 Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung ATE205072T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714656A FR2771286B1 (fr) 1997-11-21 1997-11-21 Composition cosmetique comprenant un compose de type indigoide
PCT/FR1998/002411 WO1999026586A1 (fr) 1997-11-21 1998-11-12 Composition cosmetique comprenant un compose de type indigoide

Publications (1)

Publication Number Publication Date
ATE205072T1 true ATE205072T1 (de) 2001-09-15

Family

ID=9513655

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98954562T ATE205072T1 (de) 1997-11-21 1998-11-12 Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung

Country Status (10)

Country Link
US (1) US6406685B1 (de)
EP (1) EP1032353B1 (de)
JP (1) JP3572258B2 (de)
AT (1) ATE205072T1 (de)
AU (1) AU1162699A (de)
CA (1) CA2309296C (de)
DE (1) DE69801594T2 (de)
ES (1) ES2163301T3 (de)
FR (1) FR2771286B1 (de)
WO (1) WO1999026586A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787023A1 (fr) * 1998-12-11 2000-06-16 Oreal Utilisation d'un compose indigoide dans une composition cosmetique, notamment de maquillage, pour lui conferer des proprietes anti-microbiennes et de longue tenue.
FR2810881B1 (fr) * 2000-06-30 2004-03-26 Lcw Les Colorants Wackherr Composition de laque a usage cosmetique
FR2827506A1 (fr) * 2001-07-20 2003-01-24 Oreal Composition pulverulente et son utilisation en cosmetique
US20030219391A1 (en) * 2002-02-28 2003-11-27 L'oreal Dispersed powders providing ultraviolet light protection, suitable for use in cosmetic compositions
US7534453B1 (en) 2002-09-05 2009-05-19 University Of Central Florida Research Foundation, Inc. Cerium oxide nanoparticles and use in enhancing cell survivability
US8703200B2 (en) * 2005-04-29 2014-04-22 The Board Of Regents Of The University Of Oklahoma Inhibition of neovascularization by cerium oxide nanoparticles
US7959949B2 (en) 2006-04-27 2011-06-14 University Of Central Florida Research Foundation, Inc. Functionalized nanoceria composition for ophthalmic treatment
US9119391B1 (en) 2007-07-16 2015-09-01 University Of Central Florida Research Foundation, Inc. Polymer coated ceria nanoparticles for selective cytoprotection
US8916199B1 (en) 2008-04-25 2014-12-23 University of Central Florida Research Foundation, Ind. Inhibition of angiogenesis associated with ovarian cancer by nanoparticles of cerium oxide
US9127202B1 (en) 2008-07-18 2015-09-08 University Of Central Florida Research Foundation, Inc. Biocompatible nano rare earth oxide upconverters for imaging and therapeutics
US8883519B1 (en) 2009-03-17 2014-11-11 University Of Central Florida Research Foundation, Inc. Oxidase activity of polymeric coated cerium oxide nanoparticles
US9585840B1 (en) 2009-07-10 2017-03-07 University Of Central Florida Research Foundation, Inc. Redox active cerium oxide nanoparticles and associated methods
FR2954120B1 (fr) * 2009-12-18 2012-02-24 Oreal Composition cosmetique comprenant un compose de type indigoide et un compose organique particuliers, et son utilisation en coloration.
JP2013503928A (ja) 2009-09-02 2013-02-04 ロレアル 疎水性染料、特定の無機アルカリ剤及び／又は有機アルカリ剤、特定の化合物（ｉ）及び特定の有機化合物（ｉｉ）を含む組成物、並びに染色におけるその使用
US8795731B1 (en) 2009-10-12 2014-08-05 University Of Central Florida Research Foundation, Inc. Cerium oxide nanoparticle-based device for the detection of reactive oxygen species and monitoring of chronic inflammation
WO2012036786A1 (en) 2010-09-17 2012-03-22 University Of L'aquila Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of alzheimer's disease
US8951539B1 (en) 2011-06-07 2015-02-10 University Of Central Florida Research Foundation, Inc. Methods of promoting angiogenesis using cerium oxide nanoparticles
US9161950B2 (en) 2011-09-21 2015-10-20 University Of Central Florida Foundation, Inc. Neuronal protection by cerium oxide nanoparticles
US9463437B2 (en) 2013-02-14 2016-10-11 University Of Central Florida Research Foundation, Inc. Methods for scavenging nitric oxide using cerium oxide nanoparticles
US9867761B2 (en) 2014-04-30 2018-01-16 L Star Softcoat, Llc Colored lamellar compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4427888A1 (de) * 1994-08-08 1996-02-15 Linea Conception Software Gmbh Verfahren zum Färben von Haaren
ES2115572T1 (es) * 1996-05-09 1998-07-01 Wella Ag Procedimiento y producto para el teñido del cabello.

Also Published As

Publication number Publication date
CA2309296C (fr) 2006-05-23
EP1032353B1 (de) 2001-09-05
FR2771286A1 (fr) 1999-05-28
CA2309296A1 (fr) 1999-06-03
US6406685B1 (en) 2002-06-18
EP1032353A1 (de) 2000-09-06
JP2001523697A (ja) 2001-11-27
ES2163301T3 (es) 2002-01-16
DE69801594D1 (de) 2001-10-11
DE69801594T2 (de) 2002-07-11
FR2771286B1 (fr) 1999-12-31
JP3572258B2 (ja) 2004-09-29
AU1162699A (en) 1999-06-15
WO1999026586A1 (fr) 1999-06-03

Similar Documents

Publication Publication Date Title
ATE205072T1 (de) Kosmetische zusammensetzung enthaltend eine indigotyp-verbindung
FR2674850B1 (fr) Derives s-triaziniques portant des substituants benzalmalonates, compositions cosmetiques filtrantes les contenant et leur utilisation pour proteger la peau et les cheveux du rayonnement ultraviolet.
EP0420722A3 (en) Lipid compounds, derivatives of sphingosines, process for their preparation and their use, especially in cosmetics and in dermopharmaceutics
EP0611301A4 (de) Chelat-zubereitungen, die oximverbindungen enthalten.
NZ332762A (en) Isobutylgaba and its derivatives for the treatment of pain
MY108076A (en) Cationic compound and cleaning composition.
ES2114645T3 (es) Utilizacion de un fosfato de alfa-tocoferol, o de uno de sus derivados para la preparacion de una composicion cosmetica, dermatologica o farmaceutica, de actividad anti-radicalar; composicion asi obtenida.
AU4970390A (en) Cosmetic use of benzotriazole diorganopolysiloxanes and novel cosmetic compositions containing such compounds for the protection of skin and hair
CA2006791A1 (fr) Composition de rasage pour la peau a base de polyorganosiloxanes a fonction acyloxyalkyle et procede de mise en oeuvre
HK1041879A1 (en) 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
AU3559193A (en) New 3',5'-di-tert-butyl-4'-hydroxy flavones, process for the preparation thereof and pharmaceutical compositions containing them
AU3793589A (en) New liposoluble unsaturated benzalmalonate derivatives and their use as absorbers for ultraviolet radiation in cosmetics
CA2085345A1 (en) Pyrimidine nucleoside derivatives
DE69129408D1 (de) 2(5h)- in position 3-substituierte furanone als ca 2+ antagonisten und entzündungshemmende mittel
BR9712221A (pt) Uso de pelo menos um 1,3-bis(n-lactamil) propano, composto, e, composições farmacêutica e cosmética.
ATE168105T1 (de) Melamine derivate zur verwendung in der behandlung von krebs
ATE22294T1 (de) Pyrido(3,4-c)psoralene, herstellung, verwendung in der kosmetologie und als arzneimittel und diese enthaltende zubereitungen.
WO1998049998A3 (de) Verwendung von glykosidischen siliconverbindungen zur herstellung von kosmetischen und/oder pharmazeutischen zubereitungen
AU3083692A (en) 5,5'-/(1,3-propanediyl) bis-/imino(2-oxo-2,1-ethanediyl)acetylimino/bis(2,4,6-triiod o-1,3-benzenedicarboxyamides), and contrast media containing them
HK1033455A1 (en) Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
CS742082A2 (en) Zpusob vyroby substituovanych thiazolidinylesteru mineralnich kyselin
AU2953697A (en) Vitamin d analogs and methods of preparing these compounds
HUT70761A (en) Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
NO994107L (no) Preparater for behandling eller forhindring av prostatakreft
DE69312512D1 (de) Etoposid-derivate, ihre herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee